Form4insider filings, from the source

SEC Form 4 · accession 0001225208-16-041221

WEST PHARMACEUTICAL SERVICES INC · WST

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Karen Flynn
Officer — Sr VP & Chief Commercial Offic
Period of report
Nov 4, 2016
Accepted (ET)
Nov 7, 2016 · 11:09 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockNov 4, 2016A9$75.39A1,188INon-Qualified Deferred Compensation Plan
Common Stockholding———13,580D
Common Stockholding———251IBy Savings Plan

Table II — derivative securities

No Table II lines on this filing.